Forty years since the structural elucidation of platelet-activating factor (PAF): historical, current, and future research perspectives

R Lordan, A Tsoupras, I Zabetakis, CA Demopoulos - Molecules, 2019 - mdpi.com
In the late 1960s, Barbaro and Zvaifler described a substance that caused antigen induced
histamine release from rabbit platelets producing antibodies in passive cutaneous …

Role of platelet-activating factor in cardiovascular pathophysiology

G Montrucchio, G Alloatti… - Physiological …, 2000 - journals.physiology.org
Platelet-activating factor (PAF) is a phospholipid mediator that belongs to a family of
biologically active, structurally related alkyl phosphoglycerides. PAF acts via a specific …

Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice

S Ishii, T Shimizu - Progress in Lipid Research, 2000 - Elsevier
Platelet-activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) is a
biologically active phospholipid mediator. Although PAF was initially recognized for its …

Platelet-activating factor: receptors and signal transduction

W Chao, MS Olson - Biochemical Journal, 1993 - portlandpress.com
During the past two decades, studies describing the chemistry and biology of PAF have
been extensive. This potent phosphoacylglycerol exhibits a wide variety of physiological and …

Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.

AJ Wardlaw, R Moqbel, O Cromwell, AB Kay - The Journal of clinical …, 1986 - jci.org
Platelet-activating factor (PAF-acether), an inflammatory mediator with a wide range of
biological activities including neutrophil aggregation and chemotaxis, was studied for its …

[HTML][HTML] Lysophosphatidates bound to serum albumin activate membrane currents in Xenopus oocytes and neurite retraction in PC12 pheochromocytoma cells.

G Tigyi, R Miledi - Journal of Biological Chemistry, 1992 - Elsevier
Serum contains a factor that co-purifies with albumin and causes neurite retraction in PC12
cells, inhibits the proliferation of tumor cells in vitro, and activates the phosphatidylinositol …

Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor

S Ishii, T Kuwaki, T Nagase, K Maki, F Tashiro… - The Journal of …, 1998 - rupress.org
Platelet-activating factor (PAF) is a potent phospholipid mediator with diverse biological
activities in addition to its well-known ability to stimulate platelet aggregation. Pharmacologic …

Human endothelial cells in culture produce platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when stimulated with thrombin.

SM Prescott, GA Zimmerman, TM McIntyre - Proceedings of the National …, 1984 - pnas.org
Cultured human endothelial cells produce platelet-activating factor (1-alkyl-2-acetyl-sn-
glycero-3-phosphocholine; PAF) when stimulated with human thrombin. The response to …

Characterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in …

M Miwa, T Miyake, T Yamanaka, J Sugatani… - The Journal of clinical …, 1988 - jci.org
Platelet-activating factor (PAF) acetylhydrolase has been recognized as an enzyme that
inactivates PAF. We developed a convenient and reproducible method for determining …

[HTML][HTML] A specific acetylhydrolase for 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a hypotensive and platelet-activating lipid).

ML Blank, T Lee, V Fitzgerald, F Snyder - Journal of Biological Chemistry, 1981 - Elsevier
1-Alkyl-2-acetyl-sn-glycero-3-phosphocholine, a phospholipid with platelet activating and
hypotensive properties, has an extremely labile acetate grou**. The acetate group is …